BioPorto A/S

📍 Hellerup, Denmark🗓 Founded 2000👥 13 employees💰 Last funded Apr 2017
Biotechnology🌐 bioporto.com
Website LinkedIn
BioPorto is a global in-vitro diagnostics company that provides tests and antibodies to clinicians and researchers. We use our antibody and assay expertise to transform novel research tools into clinically actionable biomarkers that can make a difference in patients’ lives. Headquartered in Hellerup, Denmark, with US headquarters outside Boston, Massachusetts, BioPorto is listed on the NASDAQ Copenhagen stock exchange. [CPH: BIOPOR] To learn more about our products and their availability in your country, visit bioporto.com or follow our LinkedIn pages: Outside the United States: https://www.linkedin.com/company/bioporto-diagnostics-a-s/ Within the US: https://www.linkedin.com/company/bioporto-diagnostics-inc-us/ Social Media Community Guidelines: https://bioporto.com/social-media/
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2000
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Denmark
1
Frequently asked questions
Who invested in BioPorto A/S?
BioPorto A/S has 1 investors on record on gritt.io.
When did BioPorto A/S last raise funding?
The most recent investment in BioPorto A/S recorded on gritt.io was in April 2017.
When was BioPorto A/S founded?
BioPorto A/S was founded in 2000.
What industry is BioPorto A/S in?
BioPorto A/S operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is BioPorto A/S based?
BioPorto A/S is headquartered in Hellerup, Denmark.